home1_b

TRIANNI and Antibody Discovery

Fully human monoclonal antibodies are powerful biological therapeutics.

Among many options available for isolating them, TRIANNI’s technology is distinguished by key advantages of ease of use, antibody diversity, and in vivo selection.

partnering
events

Antibody Engineering & Therapeutics

SCIENTIFIC BRIEFING SPONSOR
December 11–15 | San Diego, CA

16th Annual PepTalk: The Protein Science Week

PRESENTER
January 9–13, 2017  |  San Diego, CA

Biologics & Biosimilars Congress

PRESENTER
March 6–7, 2017  |  Berlin, Germany

Save

Save

Save